Papers
11
Total Citations
474
H-Index
7
About
Alexander Melamed is a leading gynecologic oncologist whose research has fundamentally reshaped surgical practice in women’s cancers, particularly cervical, endometrial, and ovarian malignancies. His landmark 2020 study in the *New England Journal of Medicine* on survival after minimally invasive versus open radical hysterectomy for early-stage cervical cancer (207 citations) challenged the safety of increasingly popular laparoscopic techniques, sparking a critical re-evaluation of surgical standards worldwide. Melamed’s work consistently examines the trade-offs between reduced morbidity and oncologic outcomes, as seen in his 2016 study showing similar survival with minimally invasive radical hysterectomy (103 citations) and his investigations into same-day discharge after laparoscopic hysterectomy for endometrial cancer (57 citations). He has also pioneered research on sentinel lymph node mapping in atypical endometrial hyperplasia and endometrial cancer, documenting its uptake and outcomes to refine staging accuracy while minimizing surgical harm. Through systematic reviews and meta-analyses, Melamed has advanced the role of minimally invasive surgery in ovarian cancer, including laparoscopic cytoreduction after neoadjuvant chemotherapy. His contributions have directly influenced clinical guidelines and surgical decision-making, making him a pivotal figure in evidence-based gynecologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3Same-Day Discharge After Laparoscopic Hysterectomy for Endometrial Cancer57 citations · 2015
- 4
- 5
- 6
- 7
- 8
- 9
- 10